MYC and acute myeloid leukemia: After the initial discovery that FTO could demethylate m6A3, a series of seminal studies used transcriptome-wide mapping of m6A sites in control and FTO-deficient AML cell lines and revealed that FTO demethylates m6A in specific regions of specific transcripts, especially the MYC mRNA.